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Abstract
Background: The 12-item General Health Questionnaire (GHQ-12) is widely used as a
unidimensional instrument, but factor analyses tended to suggest that it contains two or three
factors. Not much is known about the usefulness of the GHQ-12 factors, if they exist, in revealing
between-patient differences in clinical states and health-related quality of life.
Methods: We addressed this issue in a cross-sectional survey of out-patients with psychological
disorders in Singapore. The participants (n = 120) completed the GHQ-12, the Beck Anxiety
Inventory, and the Short-Form 36 Health Survey. Confirmatory factor analysis was used to
compare six previously proposed factor structures for the GHQ-12. Factor scores of the best-
fitting model, as well as the overall GHQ-12 score, were assessed in relation to clinical and health-
related quality of life variables.
Results: The 3-factor model proposed by Graetz fitted the data better than a unidimensional
model, two 2-factor models, and two other 3-factor models. However, the three factors were
strongly correlated. Their values varied in a similar fashion in relation to clinical and health-related
quality of life variables.
Conclusions: The 12-item General Health Questionnaire contains three factors, namely Anxiety
and Depression, Social Dysfunction, and Loss of Confidence. Nevertheless, using them separately
does not offer many practical advantages in differentiating clinical groups or identifying association
with clinical or health-related quality of life variables.
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Background
Recent studies of disease burden have demonstrated the
importance of psychological disorders. For instance,
depression was the fourth leading cause of disease bur-
den, accounting for 4.4% of total disability adjusted life
years in the world in 2000 [1]. The 12-item General
Health Questionnaire (GHQ-12) has been widely used in
many countries for detecting psychological morbidity.
Some major national studies such as the British House-
hold Panel Survey (BHPS) also employ this instrument
[2]. Calibration of this instrument may therefore contrib-
ute significantly to a large community of researchers.
While the longer versions of the GHQ are normally con-
sidered multidimensional, the GHQ-12 is often regarded
as measuring only a single dimension of psychological
health. For example, Corti [3] analyzed the GHQ-12 data
in the BHPS and maintained that the high Cronbach's
alpha value indicated the unidimensionality of this
instrument. However, several authors suggested that the
GHQ-12 contained two or three clinically meaningful fac-
tors. Using principal component analysis, Politi et al. [4]
identified two factors: general dysphoria and social dys-
function. Andrich and van Schoubroeck [5] suggested that
the positively worded items formed one factor and the
negatively worded items formed another. Graetz [6], Mar-
tin [7] and Worsely and Gribbin [8] proposed three differ-
ent 3-factor models. In a multi-centre study, although
considerable between-centre variation was found, the
final solution tended to have either two or three factors
[9].
Using confirmatory factor analysis (CFA) to analyze the
BHPS data, Cheung [10] compared various models and
found that the 3-factor model proposed by Graetz [6] gave
the best fit. The factors are anxiety and depression (4
items), social dysfunction (6 items), and loss of confi-
dence (2 items). In a study of employees in New Zealand,
Kalliath et al [11] also employed CFA to compare various
models. They also found that Graetz's 3-factor model gave
better goodness-of-fit than the others. However, they
maintained that none of the models they examined gave
a sufficient level of goodness-of-fit. Hence they modified
the instrument to propose a short (8-item) version of
GHQ. In a study of college students and young adoles-
cents in Australia, French and Tait [12] found that Graetz's
model not only fitted the data better than other models,
but also satisfactorily achieved some fit indices targets
such as Comparative Fit Index > 0.95. In a study of a rural
population in Australia [13], the model of Worsely and
Gribbin fitted best and that of Graetz was second best.
While the structure of the GHQ-12 has been studied using
factor analysis methods, the construct validity and useful-
ness of those resulting factors are not often tested. The
question is whether the additional information provided
by the 2 or 3 factors, if they exist, is clinically useful. In
other words, will multiple scores be more useful than a
total single score in helping us to understand respondents'
health status?
The purpose of this study was therefore two-fold. First, we
aimed to compare the previously proposed models of the
GHQ-12 in an oriental population and identify the best-
fitting one. It was not our objective to assess their absolute
level of fit or to derive new model or version of the GHQ.
Second, we aimed to assess whether the factors identified
relate to clinical and health-related quality of life variables
in different ways.
Methods
Subjects and study design
A consecutive sample of outpatients with anxiety disor-
ders and/or depressive disorders was recruited from a psy-
chiatric clinic at a tertiary hospital in Singapore. Inclusion
criteria were the presence of any anxiety disorder and/or
major depressive disorder, literacy in English or Chinese,
and completion of an informed consent form. Patients
with organic brain syndrome or psychosis were excluded.
During routine consultation visits, diagnoses of recruited
patients were ascertained by a psychiatrist using DSM-IV
criteria and the severity of their psychiatric disorders was
assessed using a Clinical Global Impression (CGI) scale,
which ranges from 1 (very mild) to 5 (very severe).
Patients were then given a questionnaire containing the
General Health Questionnaire (GHQ-12) [14], the Beck
Anxiety Inventory (BAI) [15], and the Short Form-36
Health Survey (SF-36) [16] for self-completion. Identical
English and Chinese questionnaires were prepared for
subjects to select according to their preference. A research
assistant checked returned questionnaires for
completeness.
Instruments
The General Health Questionnaire (GHQ-12) consists of
12 items, each assessing the severity of a mental problem
over the past few weeks using a 4-point scale (from 0 to 3).
The score was used to generate a total score ranging from
0 to 36, with higher scores indicating worse conditions
[14]. The Chinese version of GHQ-12 used in this study
had been validated [17,18]. A previous study of the 60-
and 30-item versions of English and Chinese GHQ
yielded comparable scale scores, suggesting equivalence
for the two language versions [19].
The Beck Anxiety Inventory (BAI) is a valid and reliable
self-report checklist for anxiety symptoms [15]. This
instrument consists of 21 items, each describing an anxi-
ety symptom for a respondent to assess how much he or
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she has been bothered by the symptom over the past week
on a 4-point scale. Responses to all items are summed up
to a total score ranging from 0 to 63, with higher scores
indicating more severe anxiety. A Chinese BAI was devel-
oped by the authors using forward- and back-translation
procedures, and refined after a pilot study of subjects with
anxiety disorders [20].
The Short Form 36 Health Survey (SF-36) [16] is a 36-item
questionnaire assessing functional health-related quality
of life (HRQoL) in 8 domains: physical functioning, role
limitations due to physical problems, bodily pain, general
health, vitality, social functioning, role limitations due to
emotional problems, and mental health. The instrument
yields each domain a score ranging from 0 to 100, with
higher scores indicating better HRQoL. The validity and
reliability of SF-36 have been extensively documented
[21]. In Singapore, both the UK English [16] and Chinese
(Hong Kong) [22] versions of SF-36 have been validated
[23,24] and these two language versions appear to be
equivalent [25].
Statistical analysis
Various factor structures of the GHQ-12 were tested by
confirmatory factor analysis. Model I was unidimen-
sional. Model IIA contained 2 factors: General Dysphoria
and Social Dysfunction [4]. Model IIB also contained 2
factors: positively worded items forming one factor and
negatively worded items forming another [5]. Model IIIA
contained 3 factors: Cope, Stress and Depress, identified
by Martin [7]. Model IIIB was the 3-factor model pro-
posed by Graetz [6]: Anxiety and Depression, Social dys-
function, and Loss of Confidence. Model IIIC was also a
3-factor model: Anhedonia-Sleep disturbance, Social Per-
formance and Loss of Confidence [8]. In the confirmatory
factor analysis the number of factors and the relationship
between factors and observed GHQ-12 items were pre-
specified according to the models. The loading of an item
on a factor within a model was estimated using the maxi-
mum likelihood method.
Methodologists have emphasized that it is desirable to use
different indicators to examine a model's goodness-of-fit
[26]. The fit of the six models was assessed by three meas-
ures. The Akaike's Information Criterion (AIC) penalizes
the maximum log likelihood of a model according to its
number of parameters. A model with a lower AIC is more
plausible than one with a higher AIC. Instead of showing
relative fitness, the Comparative Fit Index (CFI) assesses
the fit of a model itself. The values range between 0 and 1.
A CFI larger than 0.90 indicates an acceptable model. (Hu
and Bentler [27] suggested that a CFI value above 0.95
indicates an acceptable model. In a later section we will
discuss the more stringent cutoff.) The Root Mean Square
of Approximation (RMSEA) assesses a model's amount of
error. An RMSEA value larger than 0.08 indicates too
much error.
The best-fitting model was examined in detail. The
Kruskal-Wallis test was used to compare the GHQ-12
overall and factor scores of patients with different diagno-
sis. Pearson's correlation coefficient (r) was used to assess
the association between GHQ-12 scores and various vari-
ables, namely Beck Anxiety Inventory, Clinical Global
Impression and SF-36 scores. The Fisher's Z transforma-
tion was used to produce 95% confidence interval.
Results and Discussion
A total of 120 participants (63 man and 57 women) were
included in the analysis (Table 1). Most (90%) respond-
ents were Chinese; the mean (SD) age was 43.1 (12.7).
Sixty six percent of the participants chose to administer an
English version of the questionnaire. The mean scores of
clinical and HRQoL data reported by the respondents in
both gender were shown in Table 1. Men tended to have
Table 1: Mean (SD) clinical and SF-36 health-related quality of life values by gender
Clinical or psychological data Men (N = 63) Women (N = 57) (a)
Beck Anxiety Inventory 20.65 (13.48) 21.89 (13.59)
Clinical Global Impression 2.76 (0.84) 3.02 (0.82)
Physical Functioning 76.50 (17.88) 73.72 (17.97)
Physical Problems 51.06 (43.57) 43.42 (42.13)
Bodily Pain 62.06 (24.89) 53.46 (24.05)
General Health 49.48 (21.14) 49.21 (20.07)
Vitality 45.40 (18.15) 41.26 (19.94)
Social Functioning 56.15 (23.75) 50.22 (26.88)
Emotional Problems 39.15 (42.56) 26.32 (41.18)
Mental Health 51.05 (17.65) 46.67 (19.11)
(a) N = 56 for Clinical Global Impression scale due to a missing value.
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less anxiety, better clinical global impression, and higher
SF-36 scores.
Table 2 shows goodness-of-fit statistics for the 1-, 2- and
3-factor models. The 3-factor model (IIIB) proposed by
Graetz (1991) was the best in terms of all three fit statis-
tics. It gave the lowest AIC and RMSEA and highest CFI. Its
CFI was 0.935. All six models produced RMSEA's which
exceeded 0.08. The one-dimensional model (Model I)
had the highest AIC, highest RMSEA and lowest CFI.
Figure 1 displays the standardized factor loadings and
between-factor correlation of model IIIB. The factor
loadings ranged between 0.72 and 0.90. The three factors
were strongly correlated. The correlation between factor 1
(Anxiety and Depression) and factor 2 (Social Dysfunc-
tion) was 0.89. The correlation between factor 2 and fac-
tor 3 (Loss of Confidence) was 0.83. That between factor
1 and 3 was 0.90. These strong correlations suggest that
even if there were in fact three factors, in practice it may be
very difficult to discern them.
Having established that Graetz's 3-factor model fitted the
data better than the other models, we calculated the factor
scores as unweighted sums of the items concerned. From
figure 1 we could see that the loadings on each factor did
not vary substantially. Hence we chose to use unweighted
sums for simplicity. Table 3 shows the mean (SD) factor
scores and the overall GHQ-12 score by clinical diagnosis.
Some patients had multiple diagnoses; we categorized
them into one of three major clinical diagnoses. The three
factor scores and the overall GHQ-12 scores behaved in
fairly similar ways. All four scores were significantly differ-
ent between patients with and without depression; none
was significantly different between patients with and
without general anxiety disorder. Patients with panic dis-
order had lower scores on the factor Loss of Confidence
(difference = 0.68; P = 0.043). The SD of the two diagnosis
groups pooled was about 1.75; the between group differ-
ence was therefore approximately about 0.4 SD.
Table 4 presents the results of the correlation of 3 factors
of Graetz's model and BAI, Clinical Global Impression
Score, and SF-36 scales. The 3 factors were correlated with
the 10 clinical and HRQoL variables to very similar
degree.
Several previous confirmatory factor analyses found that
the 3-factor model of Graetz gave better fit to survey data
from Australia [12], Britain [10] and New Zealand [11]. In
this study we examined the issue in an Asian population
in Singapore, whose members are mainly ethnic Chinese.
All three goodness-of-fit indices employed, namely AIC,
CFI and RMSEA, agreed that the 3-factor model of Graetz
out-performed the other five models. The CFI value was
0.935. Conventionally, a CFI of 0.90 or larger is taken as
evidence of sufficient fit. A more stringent criterion of CFI
larger than 0.95 has recently been proposed and debated
[27,28]. The RMSEA also indicated that even the best-fit-
ting model did not fit well, using the cut-off of 0.08 as a
criterion. However, our aim is to compare the models
rather than to modify the instrument. So for our purpose
it is the comparison of the goodness-of-fit of the six mod-
els that matters, not the absolute values of the fit indices.
We consider the "correctness" and "usefulness" of a
model two fairly separate issues. Although the goodness-
of-fit of Graetz's model was limited, we proceeded to
examine the factor scores in relation to external criteria in
order to reach a conclusion about the usefulness of the
model.
The one-dimensional model was the worst according to
all three goodness-of-fit indices.
The three factors in the model proposed by Graetz were
found to be strongly correlated with each other, with cor-
relation coefficients in the neighborhood of 0.8 to 0.9.
Such strong correlations suggest that even if there were
indeed three different factors, in practice it is quite diffi-
cult to differentiate them. The study of French and Tait
[12] also showed strong correlation between the factors,
which led the authors to recommend that it may be pru-
dent to use the overall score rather than overinterpret the
factors within the GHQ-12. We examined the three factor
scores and the overall GHQ-12 score in relation to clinical
diagnoses. The four scores behaved in fairly similar ways.
Although the Loss of Confidence scale was significantly
different between patients with and without panic disor-
der while the other three scales did not show significant
differences between the two groups of patients, the differ-
ence was only about 0.4 SD. This is smaller than a recom-
mended threshold (0.5 SD) corresponding to minimal
clinically important differences for health states question-
Table 2: Goodness-of-fit of six confirmatory factor analysis models (N = 120) (a),(b)
Statistics Model I (1 factor) Model IIA (2 factors) Model IIB (2 factors) Model IIIA (3 factors) Model IIIB (3 factors) Model IIIC (3 factors)
AIC 69.529 29.220 29.956 51.611 21.075 48.956
CFI 0.888 0.927 0.925 0.908 0.935 0.910
RMSEA 0.139 0.115 0.115 0.130 0.109 0.128
(a) AIC: Akaike's Information Criterion; CFI: Comparative Fit Index; RMSEA: Root Mean-Square Error of Approximation
(b) See text for details about the models.
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naires [29]. We also examined the association between the
three GHQ scores and the Beck Anxiety Inventory, a clini-
Standardised factor loadings and between-factor correlations of Graetz's model [6]Figure 1
Standardised factor loadings and between-factor correlations of Graetz's model [6]. Boxes represent GHQ-12 items; ellipses 
represent factors. One-way and two-way arrows indicate factor loadings and between-factor correlations, respectively.
Lost sleep over worry
0.74
0.84
0.82
0.81
0.81
0.85
0.81
0.69
0.89
0.72
0.90
0.86
Anxiety and 
depression
Social
dysfunction
Loss of 
confidence
0.89
0.83
0.90
Constantly under strain 
Unhappy or depressed
Could not overcome difficulties 
Able to concentrate 
Play useful part in things 
Capable of making decisions 
Face up to problems 
Enjoy day-to-day activities
Reasonable happy
Losing confidence in self 
Thinking of self as worthless 
Health and Quality of Life Outcomes 2004, 2:63 http://www.hqlo.com/content/2/1/63
Page 6 of 7
(page number not for citation purposes)
cal impression score, and the 8 scales of the SF-36. The
three factors were associated with the clinical and HRQoL
variables to similar degrees.
Two limitations of the study should be noted. Firstly, the
sample size was somewhat small for confirmatory factor
analysis. Secondly, the participants were clinical cases.
This homogeneity might have made it more difficult to
detect variations in GHQ-12 scores. We believe that the
question about the relative plausibility of various factor
models have been sufficiently answered by this and sev-
eral previous studies [10-12]. Nevertheless, future studies
of non-clinical participants based on larger sample sizes
will be helpful to further assess the practical usefulness of
the factors of the GHQ-12.
Conclusions
Several studies, including the present one, have found that
Graetz's 3-factor model of the GHQ-12 is more plausible
than other models. However, the factors were strongly
correlated and difficult to discern. Our analysis of the
three GHQ scores in relation to clinical variables and
aspects of health-related quality of life did not appear to
be more informative than analysis of a single overall
GHQ-12 score. As such, from a pragmatic point of view
we consider it acceptable to use this instrument as a one-
dimensional measure. Unless one has specific questions
that are best answered by a subset of the three factors,
there is no need to consider the multi-dimensionality.
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Table 3: Comparison of mean (SD) values of GHQ-12 scores by clinical diagnosis.
Diagnosis N Overall GHQ-12 score Anxiety and depression 
(Factor 1)
Social dysfunction 
(Factor 2)
Loss of confidence 
(Factor 3)
Depression
Yes 60 32.15 (9.18) 11.28 (3.10) 15.73 (4.74) 5.13 (1.83)
No (Other diagnosis) 60 27.43 (6.74) 9.48 (2.86) 13.73 (3.06) 4.22 (1.62)
P-value (a) 0.002 0.002 0.010 0.005
General anxiety disorder
Yes 47 30.02 (8.10) 10.68 (2.99) 14.64 (3.96) 4.70 (1.82)
No (Other diagnosis) 73 29.64 (8.58) 10.19 (3.18) 14.79 (4.20) 4.66 (1.77)
P-value 0.712 0.410 0.987 0.993
Panic disorder
Yes 54 28.48 (7.88) 9.96 (3.08) 14.22 (3.71) 4.30 (1.69)
No (Other diagnosis) 66 30.86 (8.64) 10.73 (3.10) 15.15 (4.37) 4.98 (1.80)
P-value 0.158 0.179 0.244 0.043
(a) Kruskal-Wallis test.
Table 4: Pearson's correlation coefficients (95% confidence intervals) between GHQ-12 scores and clinical and health-related quality of 
life variables
Clinical/HRQoL scales Overall GHQ-12 score Anxiety and depression 
(Factor I)
Social dysfunction 
(Factor II)
Loss of confidence 
(Factor III)
Beck Anxiety Inventory 0.69 (0.58 to 0.77) 0.68 (0.57 to 0.77) 0.62 (0.50 to 0.72) 0.63 (0.50 to 0.72)
Clinical Global Impression 0.49 (0.34 to 0.61) 0.45 (0.29 to 0.58) 0.47 (0.31 to 0.60) 0.43 (0.27 to 0.56)
Physical functioning -0.17 (-0.34 to 0.01) -0.18 (-0.35 to 0.00) -0.16 (-0.33 to 0.02) -0.12 (-0.29 to 0.06)
Role physical -0.63 (-0.73 to -0.51) -0.60 (-0.71 to -0.48) -0.61 (-0.71 to -0.48) -0.51 (-0.63 to -0.36)
Bodily pain -0.52 (-0.68 to -0.44) -0.57 (-0.68 to -0.44) -0.43 (-0.56 to -0.27) -0.46 (-0.59 to -0.31)
General health -0.57 (-0.68 to -0.44) -0.57 (-0.68 to -0.43) -0.52 (-0.64 to -0.38) -0.50 (-0.62 to -0.35)
Vitality -0.71 (-0.79 to -0.61) -0.73 (-0.80 to -0.63) -0.63 (-0.73 to -0.51) -0.62 (-0.72 to -0.50)
Social functioning -0.65 (-0.74 to -0.54) -0.62 (-0.72 to -0.50) -0.60 (-0.70 to -0.47) -0.59 (-0.70 to -0.46)
Role emotional -0.62 (-0.72 to -0.50) -0.63 (-0.73 to -0.51) -0.55 (-0.66 to -0.41) -0.55 (-0.66 to -0.41)
Mental health -0.67 (-0.76 to -0.56) -0.67 (-0.76 to -0.56) -0.60 (-0.70 to -0.47) -0.61 (-0.71 to -0.49)
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